124 related articles for article (PubMed ID: 37822129)
1. Loss of ARHGAP40 expression in basal cell carcinoma via CpG island hypermethylation.
Yu N; Yuan B; Cai J; Liu J; Zhang W; Bao W; Wang J
Exp Dermatol; 2023 Dec; 32(12):2094-2101. PubMed ID: 37822129
[TBL] [Abstract][Full Text] [Related]
2. Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region.
Liu J; Yu N; Feng X; He Y; Lv K; Zhu H; Wang J
Anal Cell Pathol (Amst); 2022; 2022():4220786. PubMed ID: 35103233
[TBL] [Abstract][Full Text] [Related]
3. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
4. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.
Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K
Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.
Lodygin D; Yazdi AS; Sander CA; Herzinger T; Hermeking H
Oncogene; 2003 Aug; 22(35):5519-24. PubMed ID: 12934112
[TBL] [Abstract][Full Text] [Related]
7. Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide.
Kocaman N; Yuksel EI; Demir B; Calik I; Cicek D
Tissue Cell; 2022 Jun; 76():101752. PubMed ID: 35144124
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
9. Cdc42 is involved in basal cell carcinoma carcinogenesis.
Tucci MG; Lucarini G; Zizzi A; Rocchetti R; Brancorsini D; Di Primio R; Ricotti F; Ricotti G
Arch Dermatol Res; 2013 Nov; 305(9):835-40. PubMed ID: 23589095
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of LAT1 in basal cell carcinoma: implications for tumour cell survival.
Prosén S; Tina E; Sneckenborg AH; Loinder C; Seifert O; Lindberg M; Eremo AG
Clin Exp Dermatol; 2022 May; 47(5):910-917. PubMed ID: 34856000
[TBL] [Abstract][Full Text] [Related]
12. A Clinical Study of Basal Cell Carcinoma.
Kasumagic-Halilovic E; Hasic M; Ovcina-Kurtovic N
Med Arch; 2019 Dec; 73(6):394-398. PubMed ID: 32082007
[TBL] [Abstract][Full Text] [Related]
13. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma.
Brinkhuizen T; Weijzen CA; Eben J; Thissen MR; van Marion AM; Lohman BG; Winnepenninckx VJ; Nelemans PJ; van Steensel MA
PLoS One; 2014; 9(9):e106427. PubMed ID: 25181405
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
Nakayama M; Bennett CJ; Hicks JL; Epstein JI; Platz EA; Nelson WG; De Marzo AM
Am J Pathol; 2003 Sep; 163(3):923-33. PubMed ID: 12937133
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression.
Villani R; Sim SL; Roy E; Wainwright B; Francois M; Khosrotehrani K
J Dermatol Sci; 2020 Jun; 98(3):179-185. PubMed ID: 32444239
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.
Brinkhuizen T; van den Hurk K; Winnepenninckx VJ; de Hoon JP; van Marion AM; Veeck J; van Engeland M; van Steensel MA
PLoS One; 2012; 7(12):e51710. PubMed ID: 23284750
[TBL] [Abstract][Full Text] [Related]
18. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
19. From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots.
Dessinioti C; Antoniou C; Stratigos AJ
Br J Dermatol; 2017 Dec; 177(6):1485-1494. PubMed ID: 28626889
[TBL] [Abstract][Full Text] [Related]
20. Filaggrin expression via immunohistochemistry in basal cell carcinoma and squamous cell carcinoma.
Vanderbeck K; Orr CE; Parvinnejad N; Wang T; Bradshaw S; Wang A; Asai Y
J Cutan Pathol; 2021 Jul; 48(7):877-883. PubMed ID: 33543489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
